Orthopedics News and Research

RSS

Layton, LHP partner to construct new Seton Medical Center in Texas

LHP Hospital Group, Inc. of Plano, Texas, has announced the selection of Layton Construction Company, Inc. of Sandy, Utah, for construction of the new Seton Medical Center Harker Heights being developed in Harker Heights, Texas, by a joint venture between LHP and the Seton Family of Hospitals.

11 Mar 2011

Discovery: Children with severe cerebral palsy have starkly asymmetric pelvic bones

Johns Hopkins Children's Center researchers have discovered that most children with severe cerebral palsy have starkly asymmetric pelvic bones. The newly identified misalignment can affect how surgeries of the pelvis, spine and surrounding structures are performed, the researchers say.

10 Mar 2011

Vertos reports long-term safety and efficacy of mild in patients with LSS

Medical device company Vertos Medical Inc. has announced the release of clinical study data demonstrating the long-term safety and efficacy of mild as well as its superior durability over epidural steroid injections for treating lumbar spinal stenosis.

8 Mar 2011

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem, and Hadasit Medical Research Services & Development Ltd., the technology transfer company of the Hadassah University Medical Center, today announced that they have licensed innovative regenerative membrane implant technology to RegeneCure, which will further develop and commercialize the technology for bone tissue engineering for applications in trauma, spine, and reconstructive cranial and facial orthopedics.

7 Mar 2011

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Pluristem Therapeutics, Inc. and the Berlin-Brandenburg Center for Regenerative Therapies (BCRT), in cooperation with the Charite - University of Medicine in Berlin,today announced the results of a pre-clinical study demonstrating that the local administration of PLX cells following muscle injury resulted in significant improvement in the recovery of muscle function when compared with the control group. This

2 Mar 2011

Rapid advancements in joint replacement technology

Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement technology are up for reelection much more often.

21 Feb 2011

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

James C. Wittig, M.D., chief of the division of skin and sarcoma cancer at the John Theurer Cancer Center at Hackensack University Medical Center will present eleven different educational videos on innovative approaches to orthopedic oncology at the upcoming American Academy of Orthopaedic Surgeons Conference.

20 Feb 2011

New study to understand dimensions of injuries sustained by soldiers serving overseas

A team of U.S. Army orthopedic surgeons is conducting research to better understand the dimensions of injuries sustained by soldiers serving overseas. The most recent paper in their research series, presented this week at the American Academy of Orthopaedic Surgeons (AAOS) 2011 Annual Meeting, followed a single Brigade Combat Team of 4,122 soldiers over 15 months in Iraq.

19 Feb 2011

AAOS partners with Gateway EDI for claims processing and revenue management services

Today, at its Annual Meeting, the American Association of Orthopaedic Surgeons (AAOS) announced a partnership with Gateway EDI to provide claims processing and revenue management services to its membership. The AAOS Revenue Management Program powered by Gateway EDI will help AAOS members submit their claims faster and more accurately to increase revenue and cash flow.

19 Feb 2011

Platelet-rich fibrin matrix doesn't improve healing after rotator cuff repair

For years, doctors have used platelet rich plasma (PRP) to promote healing in various surgeries, but a recent study demonstrates that a type of PRP did not improve healing after rotator cuff repair.

18 Feb 2011

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

18 Feb 2011

San Francisco area patient files DePuy hip replacement recall lawsuit

Wendy R. Fleishman, a partner in the national plaintiffs' law firm Lieff Cabraser Heimann & Bernstein, LLP, announces that Alec MacPhail, of Danville, California, has filed a personal injury lawsuit against DePuy Orthopedics, Inc., and its parent company, Johnson & Johnson, Inc., for manufacturing an allegedly defective prosthetic hip implant device sold under the brand name DePuy ASR XL Acetabular System.

18 Feb 2011

CMS selects BWH to participate in Medicare Imaging Demonstration project

Brigham and Women's Hospital was selected by the Centers for Medicare & Medicaid Services as one of five conveners of a demonstration project that promotes appropriate utilization of advanced imaging services, CMS announced February 2, 2011.

17 Feb 2011

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Medtronic Inc., today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients. The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.

17 Feb 2011

Obesity and knee osteoarthritis will lead to loss of 86 million healthy years of life

An estimated 10 million Americans suffer from knee osteoarthritis (OA), making it one of the most common causes of disability in the US. Due to obesity and symptomatic knee OA, Americans over the age of 50 will together lose the equivalent of 86 million healthy years of life, concluded researchers at Brigham and Women's Hospital (BWH), who investigated the potential gains in quality and quantity of life that could be achieved averting losses due to obesity and knee OA.

16 Feb 2011

Orthofix 2010 net sales increase 3% to $564.4 million

Orthofix International N.V. today announced its results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

Aesthetic and dental surgical procedures show greater than average growth

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, standouts in surgical procedures in terms of growth over the next five years are going to be dental implant, facial injectable, optical coherence tomography (OCT) catheter, spinal nonfusion implant, and percutaneous heart valve procedures in North America.

15 Feb 2011

ConforMIS receives FDA 510(k) clearance for iTotal CR Knee Replacement System

ConforMIS has received 510(k) clearance from the U.S. Food and Drug Administration to commercially market its iTotal® CR Knee Replacement System. The iTotal CR is the only true patient-specific system available for patients who would traditionally receive a standard total knee replacement (TKR).

4 Feb 2011

Physiotherapy Associates opens physical therapy clinic in Castle Rock, CO

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, announces a new clinic location in Castle Rock, CO. The clinic offers a comprehensive range of physical therapy services, including: orthopedics; back and neck programs; hand therapy; vestibular rehabilitation; workers' compensation; orthopedic pediatrics; and foot and ankle programs.

29 Jan 2011

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Arteriocyte, a leading clinical stage biotechnology company with offices in Cleveland, Ohio and Hopkinton, Massachusetts that develops proprietary stem cell and tissue engineering based therapies, announced today approval from the Food and Drug Administration to initiate a Phase I clinical trial using its Magellan MAR01 technology in the treatment of Critical Limb Ischemia.

29 Jan 2011

Orthopedics News and Research

Layton, LHP partner to construct new Seton Medical Center in Texas

Discovery: Children with severe cerebral palsy have starkly asymmetric pelvic bones

Vertos reports long-term safety and efficacy of mild in patients with LSS

Hadasit, Yissum license innovative regenerative membrane implant to RegeneCure

Pluristem's PLX cells exhibit potential to treat accidental and intentionally induced muscle injuries

Rapid advancements in joint replacement technology

John Theurer chief to present videos on new limb-sparing surgical techniques at AAOS conference

New study to understand dimensions of injuries sustained by soldiers serving overseas

AAOS partners with Gateway EDI for claims processing and revenue management services

Platelet-rich fibrin matrix doesn't improve healing after rotator cuff repair

Study: Stretching before running neither prevents nor causes injury

San Francisco area patient files DePuy hip replacement recall lawsuit

CMS selects BWH to participate in Medicare Imaging Demonstration project

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Obesity and knee osteoarthritis will lead to loss of 86 million healthy years of life

Orthofix 2010 net sales increase 3% to $564.4 million

Aesthetic and dental surgical procedures show greater than average growth

ConforMIS receives FDA 510(k) clearance for iTotal CR Knee Replacement System

Physiotherapy Associates opens physical therapy clinic in Castle Rock, CO

FDA approves Arteriocyte's Magellan MAR01 technology for Phase I trial to treat CLI

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News